Drug or chemical induced diabetes mellitus with neurological complications with diabetic mononeuropathy
ICD-10 E09.41 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with neurological complications with diabetic mononeuropathy.
E09.41 refers to diabetes mellitus that is induced by drugs or chemicals, leading to neurological complications, specifically diabetic mononeuropathy. This condition arises when certain medications or toxic substances disrupt normal glucose metabolism, resulting in elevated blood glucose levels. The neurological complications associated with this form of diabetes can manifest as mononeuropathy, which is characterized by damage to a single nerve, often leading to pain, weakness, or sensory loss in the affected area. Common drugs that may induce this condition include corticosteroids, antipsychotics, and certain chemotherapeutic agents. Management of E09.41 involves careful monitoring of blood glucose levels, with an emphasis on maintaining HbA1c levels below 7% to minimize complications. Insulin therapy may be necessary, particularly in cases where oral hypoglycemic agents are ineffective. The presence of diabetic mononeuropathy necessitates a multidisciplinary approach to treatment, including pain management and physical therapy to improve function and quality of life.
Detailed medication history, HbA1c levels, and treatment plans.
Management of patients with drug-induced diabetes and monitoring for complications.
Ensure clear documentation of the drug responsible for diabetes and any neurological assessments.
Neurological assessments, symptom descriptions, and treatment responses.
Evaluation of patients presenting with mononeuropathy symptoms related to diabetes.
Document the relationship between diabetes and neurological symptoms clearly.
Used for follow-up visits for diabetes management.
Document patient's diabetes management plan and any complications.
Endocrinologists should ensure comprehensive documentation of diabetes control and complications.
Several classes of medications can induce diabetes, including corticosteroids, certain antipsychotics, and some chemotherapeutic agents. It is crucial to monitor blood glucose levels in patients starting these medications.
